Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of edaravone on ischemic stroke
IRCT20240224061102N1Phase 3Completed
- Sponsor
- Yasouj University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of edaravone in ischemic stroke, sponsored by Yasouj University of Medical Sciences. Started May 2024; status: completed.
02
Drugs
edaravone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20240224061102N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240224061102N1.